Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	16.84	128.80	110.24
Graham Fair Price	-2.36	6.11	6.26
PEG	-20.45	0.26	-0.33
Price/Book	-8.23	0.73	0.79
Price/Cash Flow	100.00	30.50	0.00
Prices/Earnings	8.35	-49.78	45.94
Price/Sales	-98.35	16.70	1011.84
Price/FCF	100.00	30.50	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-83.50	0.88	-5.35
Operating Margin	-96.41	0.28	7.89
ROA	-100.00	< 0.005	0.00
ROE	< 0.005	< 0.005	-15.31
ROIC	< 0.005	< 0.005	21.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.80	1.12	-37.84
EPS QOQ	1.39	-1.90	36.22
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	-0.97	58.12	5908.19
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	0.00	9.26	100.00
Inventory Turnover	0.00	1067500.00	100.00
Debt/Capitalization	0.00	0.48	100.00
Quick Ratio	0.00	0.08	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	20.07	21.30	6.10
Cash	0.43	0.15	-64.35
Capex	0.00	< 0.005	-100.00
Free Cash Flow	0.00	0.51	100.00
Revenue	0.02	0.93	5800.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	0.11	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.92	71.20	2334.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating